Gapping up
In reaction to strong earnings/guidance: HBP +19%, CGNX +14.7%, AMKR +14%, SODA +12.6%, NLS +11.7%, AVP+9.9%, CARB +9%, VECO +6.9%, MNK +6.9%, GKOS +6.4%, SALE +6.4%, RYAM +6.2%, AEIS +5.5%, BIOC +5.3%,WMB +4.3%, TSE +4.1%, SHPG +4%, WPZ +3.8%, IDXX +3.8%, XOXO +3.7%, PLOW +3.7%, TNET +3%, ATW +3%,CHGG +2.9%, AVGR +2.4%, OMEX +2.4%, (thinly traded), GAIN +2.3%, HMC +2.2%, WNR +2.2%, ABC +2%, WCG+2%, DNB +1.9%, IPI +1.8%, DAC +1.7%, CVS +1.6%, ETR +1.5%, NRZ +1.5%, AET +1.4%, ENOC +1.4%, STX+1.4%, PG +1.2%, VGZ +1.2%, PRSC +1.1%, SBRA +1%, TST +0.9%, DISCA +0.9%
M&A news:
In reaction to strong earnings/guidance: HBP +19%, CGNX +14.7%, AMKR +14%, SODA +12.6%, NLS +11.7%, AVP+9.9%, CARB +9%, VECO +6.9%, MNK +6.9%, GKOS +6.4%, SALE +6.4%, RYAM +6.2%, AEIS +5.5%, BIOC +5.3%,WMB +4.3%, TSE +4.1%, SHPG +4%, WPZ +3.8%, IDXX +3.8%, XOXO +3.7%, PLOW +3.7%, TNET +3%, ATW +3%,CHGG +2.9%, AVGR +2.4%, OMEX +2.4%, (thinly traded), GAIN +2.3%, HMC +2.2%, WNR +2.2%, ABC +2%, WCG+2%, DNB +1.9%, IPI +1.8%, DAC +1.7%, CVS +1.6%, ETR +1.5%, NRZ +1.5%, AET +1.4%, ENOC +1.4%, STX+1.4%, PG +1.2%, VGZ +1.2%, PRSC +1.1%, SBRA +1%, TST +0.9%, DISCA +0.9%
M&A news:
- CBIO +11.1% (to sell to Attenua certain oral Neuronal Nicotinic Receptor assets; may receive up to $105 mln in milestone payments plus royalties on net sales)
- NYRT +3.9% (New York REIT and The JBG Cos mutually agree to terminate their previously announced master combination agreement)
- SLW +1.5% (to acquire from Vale S.A (VALE) an additional amount of gold equal to 25% of the life of mine gold production from its Salobo mine; co gives new production guidance)
Other news:
- TRXC +30% (announces the first global sale of its ALF-X Surgical Robotic System to Humanitas Hospital in Milan, Italy)
- NXTD +10.7% (announces the issuance of patent by the USPTO for risk aware end to end multi-factor authentication )
- PSTI +10.3% (announces that it received positive feedback from the FDA on the proposed Phase III trial of its PLX-PAD cells in the treatment of critical limb ischemia), CTRV +9.8% (announces positive top-line results from Phase 1b multiple ascending dose clinical safety study of CMX157)
- KOOL +6.3% (announces that data for its proprietary technology was published in the Herald Scholarly Open Access Journal of Stem Cells Research, Development and Therapy)
- WSTL +5.5% (Cove Street Capital discloses 16.3% active stake, has entered into confidentiality agreement with the company)
- HZNP +3.8% ( secures covered status for DUEXIS and VIMOVO with CVS/Caremark (CVS))
- HRTX +3.4% (announces a 2-year term $100 mln loan agreement with Tang Capital Partners)
- BITA +1.8% ( announces that an investor consortium comprised of Tencent (TCEHY), JD.com (JD), and other investors to make investments totaling $550 mln in cash in subsidiary, Yixin Capital),
- DGLY +1.5% (receives three-year supply contract exceeding $1.0 mln for body cameras, service and storage systems),
- DRQ +1.1% (Dril-Quip discloses discloses amendment to its four-year contract with Petrobras ), .
Analyst comments:
- NEM +1.3% (initiated with a Buy at Citigroup)
- FORM +1.1% (upgraded to Buy from Hold at Stifel)
- ABX +1% (initiated with a Buy at Citigroup)
- AEO +0.8% (upgraded to Buy from Neutral at BofA/Merrill)